Galectin Therapeutics Inc. (NASDAQ: GALT) announced it has reached agreement with the U.S. Food and Drug Administration on key elements ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE